CHARLES RIVER LABORATORIES (CRL)

US1598641074 - Common Stock

197.57  -2.05 (-1.03%)

After market: 197.57 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates


2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
2.924B
11.55%
3.54B
21.08%
3.976B
12.31%
4.18B
5.13%
EBITDA
688.9M
18.63%
898.526M
30.43%
963.585M
7.24%
1.051B
9.07%
N/AN/AN/AN/A
EBIT
454M
18.66%
632.986M
39.42%
659.715M
4.22%
837.57M
26.96%
N/AN/AN/A
Operating Margin
15.53%17.88%16.59%20.04%N/AN/AN/A
EPS
8.14
20.95%
10.33
26.90%
11.13
7.74%
10.64
-4.40%

All data in USD


Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates


Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS2.39
-9.11%
Revenue1.006M
-99.90%
EBITDA246.38M
EBIT196.822K
-99.87%

All data in USD


EPS and Revenue Surprises


Recent Earnings VS Estimates (USD)
Period Reported Estimate Difference Surprise Q2 2023 2.69 2.66 0.030.95% Q1 2023 2.78 2.61 0.176.34% Q4 2022 2.98 2.77 0.217.46% Q3 2022 2.63 2.52 0.114.37% Q2 2022 2.77 2.76 0.010.30% Q1 2022 2.75 2.74 0.010.26% Q4 2021 2.49 2.46 0.031.35% Q3 2021 2.70 2.60 0.103.70%
Recent Revenue VS Estimates (USD)
Period Reported Estimate Difference Surprise Q2 2023 1.06B 1.064M 1.059B99,518.14% Q1 2023 1.029B 996.209K 1.028B103,229.02% Q4 2022 1.1B 1.045M 1.099B105,148.13% Q3 2022 989.157M 980.141K 988.177M100,819.92% Q2 2022 973.131M 1.005B -31.869M-3.17% Q1 2022 913.929M 919.21M -5.281M-0.57% Q4 2021 905.05M 897.16M 7.89M0.88% Q3 2021 895.937M 912.23M -16.293M-1.79%

EPS and Revenue Revisions


Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.21% 0.54% 1.63% 2.9%
Revenue-99.9% -99.9% 0.22% 1.26%